Arrow keys move between marks; Enter selects; F opens full screen.

Skip to content
Procura
Get started
Virongy Biosciences Inc.Report or remove this logo

Virongy Biosciences Inc. federal contracts

Correct this listing

UEIUEI: the 12-character ID the government gives every company registered for federal work. It replaced the DUNS number in April 2022. Glossary XGY3Q7EZ9JA7· CAGECAGE code: a 5-character code that identifies one company location for federal work. A company with several sites can have several. Glossary 99T06· Manassas, VA· Active registration until Jun 10, 2027· Virongy.com (opens in a new tab)

Overview

Buyers and offices that award its prime contracts, US$, active FY2021–FY2026

Obligated since award on contracts active FY2021–FY2026

Click a company to open its profile.

Buyers (sub-agency)OfficesThis companyNational Institutes ofHealth$11.7KNATIONAL INSTITUTES OF HEALTH NIAID(75N930)$11.7K · National Institutes of Health of…Virongy Biosciences Inc.$11.7K
Awards toVirongy Biosciences Inc.ConnectedCircle area = dollars

Insight NATIONAL INSTITUTES OF HEALTH NIAID (75N930) is its largest buyer. See more on the Buyers tab

1 buying office

Prime contract obligationsObligation: money the government has legally committed to a contract. It is not the same as money paid. Example: $6M obligated of a $10M ceiling. Glossary, FY2023–FY2026

$11.7K

No prime awards in FY2026 so far; last obligations in FY2023

About

From the company's SBA profile, updated Jun 2026

Virongy Biosciences Inc. is a biotechnology company dedicated to advancing viral vector technologies, diagnostic tools, and the discovery of antivirals and antibodies for viral pathogens critical to public health and biodefense. Our patented platforms, including Alpha-pseudoviruses, advanced AAV encapsulation, and Infectin™ technologies, enable rapid quantification of antivirals and neutralizing antibodies, as well as enhanced gene therapy delivery. Committed to continuous innovation and backed by decades of virology expertise, we empower clients to accelerate discoveries and address emerging viral threats.

Prime contract obligations by fiscal year, US$, FY2023–FY2026

Agencies report with a delay; the latest year will rise

Hover over a year to see its value.

FY23$11.7K

Insight Largest year: $11.7K in FY2023. See more on the Contracts tab

Prime obligations since award by state of performance, US$, contracts active FY2021–FY2026

Click a state to open its page.

AKMEVTNHWAIDMTNDMNILWIMINYRIMAORNVWYSDIAINOHPANJCTCAUTCONEMOKYWVVAMDDEAZNMKSARTNNCSCDCOKLAMSALGAHITXFLPR
  1. Virginia$11.7K · 100%
Circle area = dollarsOutlined: head office state (Virginia)

Insight 100% was performed in Virginia. See more on the Contracts tab